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Abstract
Fetal supply with long-chain PUFA (LC-PUFA) during pregnancy is important for brain growth and visual and cognitive development and is
provided by materno–fetal placental transfer. We recently showed that maternal fatty acid desaturase (FADS) genotypes modulate the
amounts of LC-PUFA in maternal blood. Whether FADS genotypes influence the amounts of umbilical cord fatty acids has not been inves-
tigated until now. The aim of the present study was to investigate the influence of maternal and child FADS genotypes on the amounts of
LC-PUFA in umbilical cord venous plasma as an indicator of fetal fatty acid supply during pregnancy. A total of eleven cord plasma n-6 and
n-3 fatty acids were analysed for association with seventeen FADS gene cluster SNP in over 2000 mothers and children from the Avon
Longitudinal Study of Parents and Children. In a multivariable analysis, the maternal genotype effect was adjusted for the child genotype
and vice versa to estimate which of the two has the stronger influence on cord plasma fatty acids. Both maternal and child FADS genotypes
and haplotypes influenced amounts of cord plasma LC-PUFA and fatty acid ratios. Specifically, most analysed maternal SNP were associated
with cord plasma levels of the precursor n-6 PUFA, whereas the child genotypes were mainly associated with more highly desaturated n-6
LC-PUFA. This first study on FADS genotypes and cord fatty acids suggests that fetal LC-PUFA status is determined to some extent by fetal
fatty acid conversion. Associations of particular haplotypes suggest specific effects of SNP rs498793 and rs968567 on fatty acid metabolism.
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A sufficient supply with PUFA and long-chain PUFA (LC-PUFA)
of the n-6 and n-3 family is important in every stage of human
life from pregnancy to adulthood for the maintenance of
metabolism and health. The PUFA and LC-PUFA composition
in blood and tissues has been associated with the occurrence
of the metabolic syndrome and CVD, immunological and
inflammatory responses and related diseases such as allergies,
early visual, cognitive and motor development, as well as
mental health and psychiatric disorders(1,2). Especially
LC-PUFA with twenty or more carbon atoms and three or
more double bonds, such as arachidonic acid (AA; 20 : 4n-6),
EPA (20 : 5n-3) and DHA (22 : 6n-3), are considered as import-
ant biologically active compounds(3,4). LC-PUFA are indispen-
sable components of cell membranes and modulate their
integrity and fluidity(5), they act as second messengers in intra-
cellular signalling pathways or regulate transcription, and
they serve as precursors for the synthesis of eicosanoids and
docosanoids, which are potent regulators of inflammatory
processes(6).
In addition to the dietary intake of LC-PUFA from animal
lipids contained in meat, eggs, fish, and in human breast
milk, they can also be synthesised endogenously from the
*Corresponding author: Dr Eva Lattka, fax þ49 89 3187 4567, email eva.lattka@helmholtz-muenchen.de
Abbreviations: AA, arachidonic acid; ALSPAC, Avon Longitudinal Study of Parents and Children; FADS, fatty acid desaturase; LC-PUFA, long-chain PUFA;
LD, linkage disequilibrium.
British Journal of Nutrition (2013), 109, 1196–1210 doi:10.1017/S0007114512003108


















Downloaded from https:/www.cambridge.org/core. IP address: 138.246.2.185, on 03 Mar 2017 at 15:53:13, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
essential fatty acids linoleic acid (18 : 2n-6) and a-linolenic
acid (18 : 3n-3) derived primarily from vegetable oils(7,8). The
rate-limiting enzymes in the desaturation–elongation cascade
of LC-PUFA synthesis are D-5 desaturase and D-6 desaturase.
A detailed overview of the complete pathway has been
shown elsewhere(9,10). Numerous genetic association studies
of SNP in the desaturase-encoding genes fatty acid desaturase
1 and 2 (FADS1 and FADS2) have reported significant associ-
ations between these SNP and fatty acid levels in various tis-
sues including serum, plasma, erythrocyte phospholipids,
adipose tissue and breast milk(11–22). Carriers of the minor
alleles showed increased levels of direct substrates of the cor-
responding desaturase reactions (18 : 2n-6, 18 : 3n-3 and
20 : 3n-6) and reduced levels of direct and derived products
of the respective desaturase reactions (for example, 18 : 3n-6,
20 : 4n-6, 22 : 4n-6, 20 : 5n-3, 22 : 6n-3), suggesting a decline
in desaturase activity due to the polymorphisms.
Supply of the fetus with PUFA and LC-PUFA during preg-
nancy, which is considered especially important for brain
growth and optimal visual and cognitive development(23), is
provided by placental transfer from the mother to the fetus
via the umbilical cord(24). The amounts of umbilical cord
fatty acids are correlated with the amounts in maternal
blood(25) and several supplementation studies have shown
that the amounts of DHA in cord blood are influenced by
the mother’s diet(26,27). The composition of LC-PUFA in
human cord blood has been suggested to be important for
later health outcomes of children. There is especially a
debate ongoing on the importance of n-6 and n-3 fatty acids
for the development of atopic diseases such as atopic derma-
titis, asthma and allergic rhinitis. Several studies have demon-
strated altered levels of especially n-6 fatty acids in atopic
patients(28–31). Few studies have also reported an association
between fatty acid composition of umbilical cord blood and
atopic disease risk or development(32–34). In the Avon Longi-
tudinal Study of Parents and Children (ALSPAC) cohort, hints
for associations between cord blood erythrocyte fatty acids
and atopic diseases have also been reported earlier, although
these associations failed to reach statistical significance after
adjusting for multiple comparisons(35). In addition to atopic
diseases, cognitive function is another important phenotype
that has been associated with cord blood fatty acid levels in
some studies(36,37). Additionally, a recent study reported
associations between cord plasma fatty acid composition
and risk for childhood adiposity(38).
In a recent study, we showed that polymorphisms in
the FADS gene cluster determine the amounts of PUFA
and LC-PUFA in erythrocyte phospholipids of pregnant
women(21) independent of maternal diet. These results suggest
that FADS genotypes may modify the fatty acid supply of the
child during pregnancy; however, proof for this hypothesis
has not been shown until now. The aim of the present
study was therefore to investigate the influence of maternal
and child FADS genotypes on the amounts of PUFA and
LC-PUFA in umbilical cord venous plasma as an indicator of
fetal fatty acid supply during pregnancy.
Methods
Subjects
The ALSPAC (http://www.alspac.bris.ac.uk) is a multi-purpose
birth cohort study based at Bristol University, England, invol-
ving over 14 000 pregnancies in the Avon area of England in
the early 1990s, the children from which have been followed
through childhood(39).
Analysis of umbilical cord venous plasma fatty acids
Umbilical cord plasma collected from the umbilical vein was
separated and frozen within 0–8 d after birth, stored at
2808C, thawed once to obtain a 100ml sample, shipped by air-
freight on dry ice to Rockville, MD, USA and thawed a second
time for analysis. Transmethylation of lipids with acetyl
chloride and methanol was performed using a simplified
method based upon the Lepage & Roy procedure(40), using
a high-throughput automated method(41). Internal calibration
was conducted by adding internal standards to each assay.
A second standard was used to quantify the exact amount of
internal standard in every batch for ongoing assay of exper-
imental variability. Freedom Evo Instrument 200 (TECAN
Trading AG) was utilised for the automatic transmethylation
and extraction of fatty acids employing the customised control
and automation software (EVOware v2.0, SP1, Patch3). The
GC 6890 Plus LAN system (Agilent Technologies, Inc.) coupled
with a fused-silica, narrow-bored DB-FFAP capillary column
(Agilent 127-32H2; 15 m £ 0·1 mm internal diameter £ 0·1mm
film thickness) was used for chromatographic separation of
the fatty acid methyl esters as reported previously(41). The
assay was linear in the range of 1–600mg/ml plasma. The
within- and between-day imprecision was 3·26 ^ 1·2 %, and
2·95 ^ 1·6 %, respectively, for fatty acid concentrations. From
twenty-two measured fatty acids in total, eleven n-6 and n-3
fatty acids were measured and expressed as a percentage by
weight of total fatty acids.
Genetic analyses
Genomic DNA was extracted from leucocytes from blood
samples obtained during pregnancy for mothers and, for the
children, from cord blood or from samples obtained at
ALSPAC clinics from age 7 years onwards(42).
SNP genotyped in the present study were chosen based on
a minor allele frequency of .10 % and linkage disequilibrium
(LD) information provided by HapMap (http://hapmap.ncbi.
nlm.nih.gov/). SNP with r 2 .0·8 were considered to have a
high degree of co-inheritance in Europeans and were there-
fore selected as ‘tagSNP’. Twelve ‘tagSNP’ (rs174576,
rs174579, rs174448, rs2727271, rs174634, rs174449, rs968567,
rs526126, rs174455, rs174602, rs498793 and rs174570) located
in the genomic region spanning FADS1, FADS2 and FADS3
were selected for genotyping together with six additional
SNP (rs174556, rs174561, rs3834458, rs174548, rs174574 and
rs174578) that have already been associated with fatty acid
levels in previous studies. A quantity of 5 ng of genomic
DNA was subjected to PCR amplification followed by the
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genotyping procedure using iPLEXTM chemistry (Sequenom)
according to the manufacturer’s protocol and a matrix-assisted
laser desorption/ionisation time-of-flight-based allele detec-
tion method. The procedure has been described in detail
elsewhere(13).
Genotyping failure rates for maternal samples ranged from
1·1 to 4·1 %. Error rates based upon about 790 duplicate
samples ranged from 0 to 0·64 %. For child DNA, failure and
error rates ranged from 2·1 to 4·8 % and from 0 to 1·3 %,
respectively, for 220 duplicate samples.
Statistics and confounding
All SNP except SNP rs174634 passed all quality criteria and
genotypes were used for statistical analysis. Linear regression
analysis was used to investigate the associations of FADS poly-
morphisms with PUFA levels. Due to the skewness of the data,
log transformations were applied to all fatty acids and all fatty
acid outcomes were standardised to have a variance of 1 to
produce more comparable effect sizes. Genetic variants
were modelled assuming a linear relationship between each
fatty acid and the number of copies of the minor allele as
has been reported in other studies(11–22). Hardy–Weinberg
equilibrium was tested using the maximum likelihood
estimate of the minor allele frequency to derive expected geno-
type frequencies. Haplotypes were generated using PLINK
version 1.07 (http://pngu.mgh.harvard.edu/,purcell/plink/).
Haplotype blocks were identified using Haploview version
4.2 (Broad Institute). Data were restricted to the haplotype
for each individual with a conditional probability exceeding
0·9 for the analyses of the two main blocks in high LD and
0·5 for haplotypes generated from all seventeen SNP. To
estimate the independent contribution of the maternal and
fetal metabolism to cord blood levels, each pair of SNP relat-
ing to the mother and offspring were entered simultaneously
into separate linear regression models.
Although genetic effects are unlikely to be confounded with
sociodemographic variables(43), the validity of results was
explored in an additional analysis adjusting for ten potential
confounders: sex of the child, multiple pregnancy (singleton,
multiple), parity (primiparous, multiparous), maternal smok-
ing at 32 weeks of gestation (yes, no), gestation, maternal
age, maternal pre-pregnancy BMI, maternal diet in pregnancy
(assessed using eighty-one food frequency questions) and a
measure of family adversity, and storage time at 48C. The
first four confounders were considered as categorical variables
while the latter six were treated as continuous variables.
To avoid complications of allele frequencies and effect sizes
varying with ethnicity, analyses were restricted to those
mothers of white ethnic origin.
Ethics
All parents signed an informed consent for the participation in
the study including approval for analysis of genetic infor-
mation. Ethical approval for the study was obtained from
the ALSPAC Law and Ethics Committee and the Local Research
Ethics Committees. The data were deemed exempt for
additional review by the Office of Human Subjects Research,
National Institutes of Health.
Results
Characteristics of the sample
Cord plasma fatty acid data with matching genetic data were
available for 3750 children (92·4 % of total samples and
36·5 % of total genotyped), of which 3368 were of white
ethnic origin. In total, fatty acid and genotype data of 2035
mother–child pairs were available.
In the adjusted analysis including ten potential sociodemo-
graphic confounders, a total number of 2659 samples were
analysed. The demographics of the sample in this adjusted
analysis are shown in online Supplementary Table 1.
The composition of umbilical cord plasma PUFA in the
ALSPAC cohort is shown in Table 1. Contents of individual
fatty acids in our cord plasma samples were generally in the
same range as in previous reports on cord plasma fatty
acids, although the mean amounts of especially AA and
DHA seem to be highly variable between studies(34,44–48).
Specifically, AA levels in the present study were slightly
lower compared with most other reports, whereas DHA
levels were in the medium range compared with other studies.
Test for Hardy–Weinberg equilibrium
Genetic variants were generally in Hardy–Weinberg equili-
brium although disequilibrium existed for rs174579 in both
mothers and children (P,0·001) and rs174570 in mothers
(P¼0·001) (see online Supplementary Table 2). In general,
heterozygotes were under-represented in these samples
although the reasons for these departures remain unclear.
Possible explanations associated with genotyping problems,
such as poor cluster separation, were not applicable for
these data. Differential fetal survival may provide an
Table 1. Fatty acids (wt % of total fatty acids) in cord plasma of 3368
children of white ethnic origin*
(Medians, interquartile ranges (IQR) and standard deviations)
Fatty acid Median IQR SD
Saturates 46·38 41·60–49·39 4·92
Monounsaturates 26·82 24·93–28·90 3·14
n-6
18 : 2 9·74 8·65–11·03 2·11
18 : 3 0·35 0·26–0·74 0·95
20 : 2 0·29 0·25–0·34 0·11
20 : 3 2·64 2·20–3·07 0·63
20 : 4 8·92 7·15–11·49 2·77
22 : 4 0·41 0·33–0·52 0·14
22 : 5 0·47 0·35–0·62 0·21
n-3
18 : 3 0·14 0·11–0·18 0·07
20 : 5 0·19 0·14–0·25 0·10
22 : 5 0·20 0·15–0·27 0·11
22 : 6 2·43 1·84–3·42 1·18
* The sample reflects observations where genetic data are present for at least one
polymorphism. All fatty acids showed evidence of skewness (P,0·001) although
the IQR suggested that the deviations from symmetry were minor for some
outcomes.
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alternative explanation(49). However, overall, these departures
were considered minor with the statistical significance reflect-
ing the large sample size. It was considered important to
report results for these two SNP but, if nevertheless these
departures reflected genotype misclassifications, it should be
noted that any associations would be biased towards the
null. Hence reported results would tend to underestimate
the true effect sizes.
Single SNP analysis
In a univariable model to analyse the associations of maternal
and child FADS genotypes with fatty acid levels separately,
most of maternal and child genotypes showed significant
associations with all analysed n-6 fatty acids, except for
g-linolenic acid (18 : 3n-6). Minor alleles were associated
with higher amounts of the shorter-chain fatty acids
18 : 2n-6, 20 : 2n-6 and 20 : 3n-6, and with lower amounts of
the longer-chain fatty acids 20 : 4n-6, 22 : 4n-6 and 22 : 5n-6
(see online Supplementary Tables 3 and 4). One exception
was the association with SNP rs498793, where the direction
of effects was the opposite of all other SNP. R 2 values that
reflect the genetically explained variability of fatty acid
concentrations ranged from 0·13 % (18 : 3n-6) to 8·48 %
(20 : 3n-6) for the seventeen maternal SNP and 0·05 %
(18 : 3n-6) to 10·69 % (20 : 3n-6) for the seventeen child SNP
(see Table 2).
Significant associations were also observed between
maternal and child SNP and the n-3 fatty acids a-linolenic
acid (18 : 3n-3) and DHA (22 : 6n-3). Carriers of minor alleles
had higher amounts of a-linolenic acid and lower amounts
of the n-3 product DHA. However, the minor allele of SNP
rs498793 in mothers was associated with higher levels of
22 : 6n-3 in cord blood, and children carrying the minor
allele had lower levels of 18 : 3n-3, which is again contrary
to the results for all other SNP (see online Supplementary
Tables 3 and 4). The genetically explained variability for n-3
fatty acids ranged from 0·29 % (18 : 3n-3) to 1·04 % (22 : 6n-3)
for the seventeen maternal SNP and from 0·13 % (20 : 5n-3)
to 0·68 % (22 : 6n-3) for the seventeen child SNP (Table 2).
In addition to the SNP effects on single fatty acids, we inves-
tigated whether the effects would be stronger and could poss-
ibly be refined by using specific fatty acid ratios to estimate
desaturase activities. In general, maternal and child genotypes
showed the same effect direction on fatty acid ratios, and
effect sizes were comparable as well. The minor alleles were
consistently associated with higher levels of the n-6 ratio
20 : 3/18 : 2, which estimates D-6 desaturase activity, lower
levels of the 20 : 4/20 : 3 ratio, which estimates D-5 desaturase
activity, and also lower levels of 20 : 4/18 : 2, which is a combi-
nation of both. Minor alleles of most SNP were also associated
with lower levels of the n-3 ratio 20 : 5/18 : 3. As in the analysis
of single fatty acids, SNP rs498793 showed the opposite in
terms of effect direction compared with all other SNP (see
online Supplementary Tables 3 and 4).
The validity of these results was explored in an additional
analysis adjusting for ten potential confounders. Overall, the
results of the initial analysis were not changed by this adjust-
ment. For instance, for AA, the effect sizes for the seventeen
mother and offspring SNP attenuated on average by only
0·7 % (range 18 % attenuation to 20 % amplification) with
similar P values (range 0·035 to 2·9£10215 in adjusted analyses
compared with 0·021 to 6·1 £ 10216 in unadjusted analyses but
restricted to the adjusted sample). In the adjusted analyses, up
to 29·4 % (AA:dihomo-g-linolenic acid ratio) of variance could
be explained by the maternal SNP and the included con-
founders, and up to 35·8 % (AA:dihomo-g-linolenic acid
ratio) of variance by the child SNP and the included confoun-
ders (Table 2).
Predominant effect of maternal FADS genotypes on less
desaturated n-6 fatty acids
Maternal and child genotypes are related to each other due to
the rules of inheritance. Therefore, in a second step, we
repeated the single SNP analysis by adjusting the maternal
genotype effect for the child genotype and vice versa. The
purpose of these analyses was to estimate which of the two
has the stronger influence on cord blood fatty acid compo-
sition, i.e. whether cord blood fatty acid composition is deter-
mined to a greater extent by fetal or maternal metabolism. By
adjusting the maternal genotype effect for the child genotype,
the minor alleles of most analysed maternal SNP were posi-
tively associated with the precursor n-6 PUFA 18 : 2n-6,
20 : 2n-6 and 20 : 3n-6 (P values between 0·020 and
3·2£10214 for 88 % of results) (Table 3). In terms of regression
coefficients, associations with 20 : 3n-6 were the strongest, fol-
lowed by 20 : 2n-6 and 18 : 2n-6. Negative and less significant
associations were observed for the n-6 LC-PUFA AA
(P,0·027) for ten of the seventeen analysed SNP and adrenic
acid (P,0·033) for four SNP. In the initial unadjusted analysis,
Table 2. Maximum R 2 (%) across the seventeen genetic variants
by mother–offspring for each fatty acid and ratio (log transformed) in
unadjusted analyses (reflecting the genetic association) and in adjusted
analyses (including the effect of confounders)
Unadjusted Adjusted
Mother Offspring Mother Offspring
n-6
18 : 2 3·28 1·10 16·97 14·20
18 : 3 0·13 0·05 5·26 5·58
20 : 2 2·21 1·03 8·52 7·59
20 : 3 8·48 10·69 16·11 19·16
20 : 4 1·86 2·99 10·41 9·00
22 : 4 0·71 1·26 9·30 9·66
22 : 5 0·40 0·89 11·09 10·46
20 : 3/18 : 2 3·02 6·52 15·50 19·44
20 : 4/20 : 3 23·07 31·24 29·40 35·81
20 : 4/18 : 2 6·06 5·63 19·79 16·84
n-3
18 : 3 0·29 0·52 13·45 12·98
20 : 5 0·23 0·13 10·63 10·30
22 : 5 0·29 0·18 12·99 13·67
22 : 6 1·04 0·68 8·10 7·56
20 : 5/18 : 3 0·45 0·54 10·21 9·85
Maximum n 2491 2876 1983 2287
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Table 3. Regression coefficients from analyses of log n-6 and n-3 fatty acid levels as a percentage of total fatty acid levels on maternal fatty acid desaturase (FADS) SNP adjusted for child genotype†
(Regression coefficients with their standard errors)
FADS1 Intergenic FADS2
rs174548 rs174556 rs174561 rs3834458 rs968567 rs174570 rs174574
Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE
n-6
18 : 2 0·190*** 0·037 0·199*** 0·037 0·201*** 0·037 0·219*** 0·036 0·105* 0·045 0·219*** 0·050 0·215*** 0·036
18 : 3 0·046 0·039 0·044 0·040 0·050 0·040 0·063 0·039 0·032 0·048 0·004 0·054 0·058 0·038
20 : 2 0·209*** 0·036 0·203*** 0·037 0·212*** 0·037 0·221*** 0·036 0·146** 0·045 0·206*** 0·050 0·222*** 0·035
20 : 3 0·253*** 0·036 0·265*** 0·036 0·275*** 0·036 0·253*** 0·035 0·241*** 0·045 0·146** 0·052 0·251*** 0·035
20 : 4 20·093* 0·038 20·095* 0·038 20·091* 0·038 20·126*** 0·037 20·084 0·046 20·077 0·052 20·115** 0·037
22 : 4 20·053 0·038 20·068 0·039 20·053 0·039 20·093* 0·038 20·076 0·046 20·018 0·053 20·079* 0·037
22 : 5 0·002 0·039 20·018 0·039 20·003 0·039 20·039 0·038 20·042 0·047 0·009 0·053 20·020 0·038
20 : 3/18 : 2 0·101** 0·038 0·106** 0·038 0·114** 0·038 0·078* 0·037 0·156*** 0·046 20·028 0·053 0·079* 0·037
20 : 4/20 : 3 20·388*** 0·031 20·403*** 0·031 20·408*** 0·031 20·430*** 0·030 20·362*** 0·043 20·254*** 0·050 20·414*** 0·030
20 : 4/18 : 2 20·217*** 0·038 20·224*** 0·038 20·222*** 0·038 20·268*** 0·037 20·152** 0·047 20·218*** 0·052 20·254*** 0·036
n-3
18 : 3 0·039 0·037 0·018 0·038 0·018 0·037 0·037 0·036 20·003 0·045 0·021 0·051 0·041 0·036
20 : 5 20·048 0·037 20·046 0·037 20·040 0·038 20·041 0·036 20·079 0·045 20·000 0·051 20·039 0·036
22 : 5 20·002 0·038 20·019 0·038 20·008 0·038 20·018 0·037 20·048 0·046 20·010 0·052 20·019 0·037
22 : 6 20·086* 0·038 20·097* 0·038 20·086* 0·038 20·116** 0·037 20·095* 0·046 20·075 0·052 20·108** 0·037
20 : 5/18 : 3 20·070 0·037 20·053 0·037 20·047 0·038 20·063 0·036 20·065 0·045 20·016 0·051 20·064 0·036
n 1938 1924 1943 1938 2003 1949 1943
FADS2
rs2727271 rs174576 rs174578 rs174579 rs174602 rs498793 rs526126
Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE
n-6
18 : 2 0·218*** 0·056 0·212*** 0·036 0·210*** 0·036 0·158*** 0·041 0·136** 0·043 20·020 0·036 0·047 0·045
18 : 3 0·053 0·061 0·048 0·039 0·056 0·038 0·029 0·044 0·048 0·046 20·049 0·038 0·066 0·048
20 : 2 0·191*** 0·056 0·226*** 0·036 0·226*** 0·035 0·185*** 0·041 0·130** 0·042 20·036 0·036 0·047 0·045
20 : 3 0·185** 0·057 0·247*** 0·035 0·245*** 0·035 0·242*** 0·041 0·101* 0·044 20·013 0·037 0·068 0·046
20 : 4 20·089 0·058 20·126*** 0·037 20·115** 0·037 20·093* 0·042 20·059 0·044 0·096** 0·037 20·116* 0·046
22 : 4 20·042 0·059 20·092* 0·038 20·079* 0·037 20·079 0·042 20·051 0·044 0·048 0·037 20·071 0·046
22 : 5 0·018 0·059 20·051 0·038 20·035 0·038 20·041 0·043 0·014 0·045 0·033 0·038 20·047 0·047
20 : 3/18 : 2 0·011 0·059 0·077* 0·037 0·078* 0·037 0·115** 0·042 20·007 0·045 0·003 0·038 0·030 0·047
20 : 4/20 : 3 20·311*** 0·056 20·424*** 0·030 20·409*** 0·030 20·375*** 0·039 20·184*** 0·043 0·140*** 0·037 20·224*** 0·046
20 : 4/18 : 2 20·230*** 0·059 20·264*** 0·037 20·251*** 0·036 20·195*** 0·042 20·147** 0·045 0·110** 0·038 20·148** 0·047
n-3
18 : 3 0·044 0·057 0·026 0·037 0·031 0·036 0·001 0·041 0·043 0·043 20·072* 0·036 0·020 0·045
20 : 5 0·014 0·057 20·043 0·037 20·043 0·036 20·071 0·041 20·028 0·043 0·014 0·036 20·061 0·045
22 : 5 0·065 0·058 20·023 0·037 20·019 0·037 20·064 0·042 0·008 0·043 0·008 0·037 20·023 0·046
22 : 6 20·060 0·058 20·120** 0·037 20·115** 0·036 20·110** 0·042 20·035 0·044 0·057 0·037 20·099* 0·046
20 : 5/18 : 3 20·021 0·057 20·056 0·037 20·059 0·036 20·061 0·041 20·056 0·043 0·066 0·036 20·067 0·045
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Coefficient SE Coefficient SE Coefficient SE
n-6
18 : 2 0·162*** 0·035 0·163*** 0·036 0·120*** 0·036
18 : 3 0·083* 0·038 0·081* 0·038 0·077* 0·039
20 : 2 0·155*** 0·035 0·154*** 0·035 0·137*** 0·036
20 : 3 0·199*** 0·035 0·201*** 0·036 0·146*** 0·037
20 : 4 20·058 0·036 20·060 0·037 20·073 0·037
22 : 4 20·021 0·037 20·023 0·037 20·027 0·038
22 : 5 0·011 0·037 0·010 0·038 20·002 0·038
20 : 3/18 : 2 0·070 0·037 0·071 0·037 0·050 0·038
20 : 4/20 : 3 20·285*** 0·033 20·290*** 0·034 20·248*** 0·035
20 : 4/18 : 2 20·163*** 0·036 20·165*** 0·037 20·151*** 0·038
n-3
18 : 3 0·028 0·035 0·024 0·036 0·027 0·036
20 : 5 20·061 0·035 20·066 0·036 20·041 0·036
22 : 5 20·008 0·036 20·002 0·036 0·023 0·037
22 : 6 20·072* 0·036 20·063 0·036 20·068 0·037
20 : 5/18 : 3 20·073* 0·035 20·074* 0·036 20·055 0·036
n 1966 1945 1956
* P,0·05, ** P,0·01, *** P,0·001.
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the genetically explained variances of 18 : 2n-6 and 20 : 2n-6
were higher for the maternal than for the child SNP
(Table 2), which might also reflect the predominant influence
of the maternal genotype on the levels of these fatty acids.
Amounts of 18 : 3n-6 and 22 : 5n-6 were not associated with
any of the tested maternal SNP. Effect sizes of the ratio associ-
ations were slightly attenuated when the maternal genotype
was adjusted for the child genotype (see online Supplemen-
tary Table 3 and Table 4).
Predominant effect of child FADS genotypes on highly
desaturated n-6 fatty acids
Associations of child genotypes with cord blood fatty acid
levels adjusted for maternal genotype resulted in positive
associations with the precursor PUFA 20 : 3n-6 for all analysed
SNP (P values between 0·017 and 3·5£10224) (Table 4).
Regression coefficients for this association were generally
higher than in the maternal SNP analysis. In contrast to the
maternal SNP results, we also found strong negative associ-
ations between minor alleles of the child SNP and the n-6
LC-PUFA 20 : 4n-6, 22 : 4n-6 and 22 : 5n-6 (P values between
0·038 and 1·7£1028 for 80 % of results), with 20 : 4n-6 exhibit-
ing the highest regression coefficients of these three LC-PUFA.
In the initial unadjusted analysis, the genetically explained
variances of 20 : 3n-6, 20 : 4n-6, 22 : 4n-6 and 22 : 5n-6 were
higher for the child than for the maternal SNP (Table 2),
which might also reflect the predominant influence of the
child genotype on the levels of these fatty acids. The PUFA
18 : 3n-6 was not significantly associated with child FADS
genotypes, and 18 : 2n-6 and 20 : 2n-6 showed only
sporadic associations. Again, effect sizes of the ratio associ-
ations were slightly attenuated when the offspring genotype
was adjusted for the maternal genotype (see online
Supplementary Tables 3 and 4).
Associations with n-3 long-chain-PUFA in the
multivariable analysis
By adjusting the maternal genotype effect for the child geno-
type, negative associations were observed for the n-3 LC-PUFA
DHA (P,0·046) for eleven SNP. Amounts of 22 : 5n-6,
18 : 3n-3, 20 : 5n-3 and 22 : 5n-3 were not associated with any
of the tested maternal SNP while 18 : 3n-6 was only associated
with one SNP (Table 3). In the vice versa analysis (child gen-
otype effect adjusted for maternal genotype), negative associ-
ations with DHA were also observed for six SNP (P,0·0499)
with a comparable regression coefficient to the maternal
SNP analysis (Table 4). Additionally, in contrast to the results
for the maternal genotype effect, ten SNP were associated
with amounts of a-linolenic acid (18 : 3n-3) (P,0·042), with
minor allele carriers exhibiting higher levels of this fatty
acid. This was also reflected in the higher genetically
explained variance of 18 : 3n-3 for the seventeen child SNP
compared with the maternal SNP (0·52 v. 0·29 %) (Table 2).
Similar to the maternal SNP analysis, the n-3 fatty acids
20 : 5n-3 and 22 : 5n-3 were rarely associated with child
FADS genotypes (6 % of results). The n-3 ratio 20 : 5/18 : 3
was hardly associated with any SNP when the maternal geno-
type was adjusted for the offspring genotype and vice versa
(12 and 29 % of the results, respectively). Overall, the seven-
teen SNP had lower R 2 with all of the n-3 fatty acids than
with any of the n-6 fatty acids except 18 : 3n-6 (see Table 2).
Haplotype analysis
To further investigate the genetic associations, haplotypes
were generated from the seventeen SNP for mother and off-
spring separately. Analysis of haplotype blocks identified
three regions of high LD (see online Supplementary Fig. 2).
Due to the high recombination levels between the first two
regions (D’ ¼ 0·96), these regions were combined. Haplotypes
were constructed for the associated ten SNP and were
restricted to data with probabilities .0·9. rs174570, although
within the region rs174548 to rs174579, was left unspecified
due to its relatively low LD with other SNP. A total of five
haplotypes (frequency .1 %) were derived for this region
with about 3 % of the genetic variation associated with rare
haplotypes (see online Supplementary Table 5). Of those
three, the haplotype representing all the major alleles
(Hap1) generally showed the strongest association with fatty
acids (see online Supplementary Tables 6 and 7). Multivariate
tests across the fifteen outcomes for each of the five minor
haplotypes suggested that all haplotypes contributed to the
explanation of outcomes (P,0·001). To explore their associ-
ations further, equality of regression coefficients for the
minor haplotypes was tested. The main differences between
haplotypes related to the n-6 fatty acids with two or three
unsaturated bonds and the ratios derived from these fatty
acids, although differences were also observed for offspring
haplotypes on 22 : 5n-6 (Hap1 column; see online Supplemen-
tary Table 10). If their effects were equal, it implied that Hap1
could serve as a proxy for these haplotypes due to their linear
dependency. Even where differences between the minor hap-
lotypes existed, the contribution was ,1 % over and above
that of Hap1 (difference R 2 for Max and Hap1 columns; see
online Supplementary Table 10). Subsequent models explored
the relative importance of the minor haplotypes. Hap5,
Hap4 and then Hap3 made decreasing contributions to
the explanation of outcomes (see online Supplementary
Table 10). Statistically, Hap1 could be used to reflect Hap2
and Hap.rare (and Hap3 for maternal haplotypes) although
parsimony may not be the over-riding goal. These rare
haplotypes may reflect distinct effects that the present study
was underpowered to detect.
Although the minor haplotypes made only little contribution
to the explanation of fatty acid levels, comparison between
Hap3 and Hap5 might suggest a specific role of SNP
rs968567 for fatty acid metabolism. Specifically, Hap3 and
Hap5 differ only in the presence or absence of the rs968567
minor allele (see online Supplementary Table 5). Maternal
Hap3 showed hardly any significant associations with fatty
acids (which, however, may have been due to a lack of
power with the haplotype frequency being 1·6 %), whereas
maternal Hap5 (which contains the minor allele of rs968567)
was significantly associated with various fatty acids including
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Table 4. Regression coefficients from analyses of log n-6 and n-3 fatty acid levels as a percentage of total fatty acid levels on child fatty acid desaturase (FADS) SNP adjusted for the maternal geno-
type†
(Regression coefficients with their standard errors)
FADS1 Intergenic FADS2
rs174548 rs174556 rs174561 rs3834458 rs968567 rs174570 rs174574
Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE
n-6
18 : 2 0·044 0·038 0·042 0·038 0·030 0·038 0·057 0·037 20·025 0·045 0·137* 0·053 0·059 0·037
18 : 3 0·002 0·041 0·008 0·041 0·000 0·041 20·011 0·040 0·045 0·048 20·053 0·057 20·017 0·040
20 : 2 0·025 0·038 0·018 0·038 0·026 0·038 0·022 0·037 20·086 0·045 0·144** 0·053 0·032 0·037
20 : 3 0·368*** 0·037 0·379*** 0·037 0·362*** 0·037 0·371*** 0·036 0·295*** 0·045 0·238*** 0·054 0·365*** 0·036
20 : 4 20·219*** 0·039 20·218*** 0·039 20·220*** 0·039 20·198*** 0·038 20·122** 0·047 20·212*** 0·055 20·202*** 0·038
22 : 4 20·156*** 0·039 20·144*** 0·040 20·155*** 0·039 20·120** 0·039 20·116* 0·047 20·094 0·056 20·126** 0·039
22 : 5 20·154*** 0·040 20·136*** 0·040 20·143*** 0·040 20·124** 0·039 20·009 0·048 20·212*** 0·056 20·135*** 0·039
20 : 3/18 : 2 0·330*** 0·039 0·343*** 0·039 0·336*** 0·039 0·323*** 0·038 0·313*** 0·046 0·128* 0·056 0·315*** 0·038
20 : 4/20 : 3 20·674*** 0·032 20·683*** 0·032 20·670*** 0·032 20·649*** 0·031 20·470*** 0·043 20·528*** 0·053 20·648*** 0·031
20 : 4/18 : 2 20·250*** 0·039 20·247*** 0·039 20·242*** 0·039 20·237*** 0·038 20·107* 0·047 20·302*** 0·055 20·242*** 0·038
n-3
18 : 3 0·090* 0·038 0·106** 0·039 0·104** 0·038 0·093* 0·037 0·048 0·046 0·136* 0·054 0·077* 0·038
20 : 5 20·004 0·038 0·005 0·038 0·001 0·038 20·006 0·038 20·010 0·045 20·001 0·054 20·013 0·038
22 : 5 20·017 0·039 20·003 0·039 20·015 0·039 0·012 0·038 20·062 0·046 0·107* 0·054 0·014 0·038
22 : 6 20·094* 0·039 20·081* 0·039 20·092* 0·039 20·069 0·038 20·053 0·046 20·052 0·055 20·075* 0·038
20 : 5/18 : 3 20·070 0·038 20·075 0·038 20·076* 0·038 20·074* 0·038 20·044 0·046 20·102 0·054 20·068 0·038
n 1938 1924 1943 1938 2003 1949 1943
FADS2
rs2727271 rs174576 rs174578 rs174579 rs174602 rs498793 rs526126
Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE
n-6
18 : 2 0·070 0·056 0·050 0·037 0·055 0·037 0·020 0·041 0·059 0·043 0·001 0·036 0·035 0·045
18 : 3 20·081 0·060 20·007 0·040 20·012 0·040 0·052 0·044 20·028 0·046 0·037 0·039 20·010 0·048
20 : 2 0·147** 0·055 0·031 0·037 0·026 0·037 20·069 0·041 0·084* 0·043 20·058 0·036 0·046 0·045
20 : 3 0·279*** 0·057 0·370*** 0·036 0·365*** 0·036 0·259*** 0·041 0·158*** 0·044 20·088* 0·037 0·146** 0·046
20 : 4 20·204*** 0·058 20·200*** 0·038 20·204*** 0·038 20·129** 0·042 20·092* 0·044 0·082* 0·037 20·059 0·046
22 : 4 20·072 0·058 20·126** 0·039 20·133*** 0·039 20·112** 0·042 20·039 0·044 0·058 0·037 20·096* 0·046
22 : 5 20·204*** 0·058 20·116** 0·040 20·124** 0·039 20·045 0·043 20·078 0·045 0·062 0·038 20·041 0·047
20 : 3/18 : 2 0·221*** 0·058 0·327*** 0·039 0·318*** 0·038 0·241*** 0·042 0·110* 0·045 20·089* 0·038 0·118* 0·047
20 : 4/20 : 3 20·560*** 0·055 20·651*** 0·031 20·650*** 0·031 20·441*** 0·039 20·287*** 0·044 0·201*** 0·037 20·231*** 0·046
20 : 4/18 : 2 20·251*** 0·058 20·235*** 0·038 20·241*** 0·038 20·143*** 0·042 20·131** 0·045 0·082* 0·038 20·082 0·047
n-3
18 : 3 0·160** 0·056 0·087* 0·038 0·081* 0·038 0·040 0·041 20·026 0·043 20·020 0·036 20·018 0·045
20 : 5 0·007 0·056 20·021 0·038 20·016 0·037 20·020 0·041 20·031 0·043 0·031 0·036 20·020 0·045
22 : 5 0·056 0·057 0·003 0·038 0·000 0·038 20·023 0·042 20·045 0·044 0·032 0·037 20·090* 0·046
22 : 6 20·047 0·057 20·077* 0·038 20·075* 0·038 20·065 0·042 20·069 0·044 0·048 0·037 20·057 0·046
20 : 5/18 : 3 20·113* 0·056 20·082* 0·038 20·074* 0·038 20·047 0·041 20·007 0·043 0·041 0·036 20·004 0·045
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Coefficient SE Coefficient SE Coefficient SE
n-6
18 : 2 0·044 0·036 0·048 0·037 0·061 0·037
18 : 3 20·002 0·039 20·005 0·039 20·014 0·039
20 : 2 0·016 0·036 0·018 0·036 0·042 0·037
20 : 3 0·210*** 0·036 0·214*** 0·037 0·227*** 0·037
20 : 4 20·156*** 0·037 20·156*** 0·038 20·116** 0·038
22 : 4 20·137*** 0·037 20·133*** 0·038 20·088* 0·038
22 : 5 20·149*** 0·038 20·146*** 0·039 20·108** 0·039
20 : 3/18 : 2 0·174*** 0·037 0·175*** 0·038 0·177*** 0·038
20 : 4/20 : 3 20·425*** 0·034 20·429*** 0·035 20·390*** 0·035
20 : 4/18 : 2 20·186*** 0·037 20·188*** 0·038 20·156*** 0·038
n-3
18 : 3 0·070 0·036 0·077* 0·037 0·064 0·037
20 : 5 0·010 0·036 0·008 0·037 0·026 0·037
22 : 5 20·033 0·037 20·031 0·037 20·008 0·037
22 : 6 20·067 0·037 20·065 0·037 20·028 0·037
20 : 5/18 : 3 20·043 0·036 20·050 0·037 20·025 0·037
n 1966 1945 1956
* P,0·05, ** P,0·01, *** P,0·001.
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22 : 6n-3 and fatty acid ratios. However, none of these differ-
ences was statistically significant. For offspring haplotypes,
differences between Hap3 and Hap5 were observed for
18 : 2n-6 (P¼0·003), 20 : 5n-6 (P¼0·010) and 20 : 4/18 : 2
(P¼0·005), with genetic effects being reduced in Hap5.
Also, SNP rs498793 was atypical due to its negative LD with
other SNP. To further explore this variant, haplotypes were
constructed for all seventeen SNP. Due to the low LD between
some SNP and the large number of SNP, a plethora of haplo-
types was generated, with some individuals having many
possible alternatives. A weaker criterion of haplotype assign-
ment, probability .0·5, was chosen to increase the number
of individuals in subsequent fatty acid analyses. Over 300
rare haplotypes were identified representing about 26 % of
the genetic variation (see online Supplementary Table 8).
Only two haplotypes had frequencies above 5 % – one invol-
ving major alleles for all SNP and the other with the minor
allele for rs498793 only. This latter haplotype, reflecting the
negative LD between rs498793 and other SNP, showed much
stronger results than its associated SNP (compare Tables 3
and 4 with online Supplementary Table 9).
Multiple comparisons
In the univariable analyses, hypotheses relating to seventeen
genetic variants by mother and offspring for the eleven fatty
acids were being tested. Due to their derivation from these
data, the results from fatty acid ratios and haplotypes were
excluded from this analysis. Of these 374 comparisons, 132
had nominal P.0·05, 242 had P,0·05, 203 had P,0·01, 173
had P,0·001 and 140 had P,0·0001. This distribution of the
observed P values differed markedly from that expected if
all 374 comparisons were null. In particular, 65 % of observed
P values were less than the 5 % significance level compared
with 5 % (by definition) for the null scenario. Even using the
overly conservative Bonferroni correction, 38 % of tests
would have remained significant. A more powerful method
adjusting for multiple comparisons, the false discovery
rate(50), suggested that the adjusted 5 % critical P value was
0·0302. Only nineteen of the 242 nominally significant
P values failed to satisfy this adjusted critical value. The
minor adjustment to the nominal value of 0·05 reflected the
early divergence in the distributions of observed and expected
P values (see online Supplementary Fig. 1).
A similar pattern emerged for multivariable analyses when
mother–offspring variants were jointly assessed (see Fig. 1).
As expected, P values were higher in these analyses partly
due to the correlation between mother–offspring genotypes
introduced by inheritance. Nevertheless, 159 (41 %) results
had P,0·05, with 121 having P,0·0163 (false discovery rate
criterion), eighty with P,0·001, and sixty-three (17 %) with
P,0·000134 (Bonferroni criterion).
Discussion
In the present study it was shown that concentrations of cord
venous plasma fatty acids are dependent on both the maternal
and child genotype of selected polymorphisms in the FADS
gene cluster. Maternal genotypes mainly influenced the
concentrations of less desaturated n-6 fatty acids (18 : 2n-6,
20 : 2n-6 and 20 : 3n-6), whereas child genotypes had a predo-
minant effect on more highly desaturated n-6 fatty acids
(20 : 4n-6, 22 : 4n-6 and 22 : 5n-6). The concentrations of
DHA were dependent on both the maternal and child
genotype, whereas the amounts of a-linolenic acid were
only associated with the child genotypes.
Effect of FADS SNP and haplotypes on cord venous plasma
fatty acids and fatty acid ratios
An effect of FADS genotypes on the composition of LC-PUFA
in various tissues including serum, plasma, erythrocyte phos-
pholipids, adipose tissue and breast milk has been shown in
numerous previous studies(11–22). To our knowledge, the pre-
sent study is the first to investigate the effect of maternal as
well as child genotypes on cord venous plasma fatty acid com-
position. In our analysis, we generally observed increased
levels of the direct precursors of the D-5 desaturase and D-6
desaturase reactions and lower levels of direct or derived
products of the respective desaturase reactions in carriers of
minor alleles, which is in accordance with the results from
previous studies in other tissues.
Also the direction of SNP associations with specific ratios
was generally as expected. The n-6 ratio 20 : 4/20 : 3, which
is a direct estimate of the D-5 desaturase reaction, decreased
significantly per copy of the minor allele and per copy of
those haplotypes that contained minor alleles of the analysed
SNP (except rs498793), which is in line with the general
assumption that minor allele carriers exhibit lower D-5 desa-


































Fig. 1. Q-Q plot of 374 multivariable genetic comparisons (11 fatty acid
outcomes £ 17 genetic variants £ mother/offspring) reported in Tables 3
and 4. The graph shows the distribution of the observed ranked P values ( ;
least significant to the most highly significant) and the expected distribution if
all 374 comparisons were null ( ). At the 5 % level ( ), 154 (41 %)
results were significant while, using the Bonferroni adjustment ( ), sixty-
three (17 %) were significant. The false discovery rate (FDR) criterion will
always lie between these two extremes, with its precise value depending on
the observed distribution. For these data, the FDR criterion was calculated
as 0·0163.
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FADS2 promoter SNP rs968567 was the only SNP in their study
that was associated with increased serum phospholipid D-6
desaturase ratios (20 : 3n-6/18 : 2n-6) in carriers of minor
alleles. In the present study, the minor alleles of all analysed
SNP were associated with an increase of the 20 : 3n-6/
18 : 2n-6 ratio. Bokor et al.(19) concluded in their study that
the increase of the 20 : 3n-6/18 : 2n-6 ratio might be a conse-
quence of an increase in D-6 desaturase activity due to
the minor allele of rs968567, which agrees with an earlier
in vitro study on the effect of this polymorphism on FADS2
promoter activity(51). In our present study, we found this
effect also for all other analysed SNP in addition to
rs968567. Whether the minor alleles of the investigated FADS
polymorphisms really lead to an increase in D-6 desaturase
activity, or whether the increase of the D-6 desaturase ratio
is rather due to the massive accumulation of 20 : 3n-6 resulting
from a decrease in D-5 desaturase activity can hardly be
judged from the present data. A better estimate of D-6 desatur-
ase activity would be the 18 : 3n-6/18 : 2n-6 ratio because
18 : 3n-6 is the immediate product of the D-6 desaturase reac-
tion. Due to the very low concentration of 18 : 3n-6, which is
very rapidly elongated to 20 : 3n-6, the precision of assessing
the 18 : 3n-6/18 : 2n-6 ratio is rather limited. Further studies
are therefore needed to analyse the particular effect of FADS
minor alleles on desaturase activities.
In general, the contribution of FADS genetic variants to fatty
acid concentrations in cord venous plasma was apparently
rather low (for example, 1·86 % of the amount of AA in cord
venous plasma could be explained by the maternal FADS geno-
type and 2·99 % by the offspring genotype). In the adjusted
analysis (including the effects of all potential confounders
such as maternal diet), 10·41 % of AA variability could be
explained when the maternal genotype was included and
9·00 % could be explained when the offspring genotype was
included, suggesting that factors such as maternal diet, age,
smoking, etc. add more to the effect on fatty acid levels
than the genetic background. However, the genetically
explained variability of the 20 : 4n-6/20 : 3n-6 ratio, which
reflects D-5 desaturase activity, was .20 % for maternal geno-
types and .30 % for offspring genotypes and increased only
slightly when confounders were included (Table 2). Usage
of fatty acid concentration ratios as proxies for enzymic reac-
tion rates has earlier already been shown to reduce variance
and yield robust statistical associations with very high geneti-
cally explained variabilities of the respective ratios. In the
study by Illig et al.(52) a SNP in the FADS1 gene explained
more than 30 % of variability of the serum phosphatidyl-
choline (PC) ratio PC aa C36 : 3/PC aa C36 : 4, which is also
an estimate of the D-5 desaturase reaction(52). The present
study confirms these previous findings and suggests a strong
genetic effect on D-5 desaturase activity.
Evidence for fetal capacity of synthesising
long-chain-PUFA
The fact that maternal genotypes were mainly associated with
the less desaturated n-6 fatty acids and the child genotypes
were mainly associated with the more highly desaturated
n-6 fatty acids in our multivariable analysis suggests that the
fetus might be able to synthesise n-6 LC-PUFA by itself to a
certain extent. The current view of fetal fatty acid accumu-
lation during pregnancy is that it mainly takes place through
preferential placental transfer of LC-PUFA from the mother
to the child(24). At least for DHA, this view is supported by var-
ious tracer studies on placental fatty acid transfer, which
detected increased DHA accumulation in the placenta(53) as
well as preferential materno–fetal transfer across the placenta
after tracer administration(54,55). For the n-6 fatty acids, data
are more scarce, but suggest lower placental transfer selectiv-
ity compared with DHA(56). Furthermore, it has been shown
that desaturation capacity in the human fetus and newborn
is apparently lower than in adult humans and other species,
for example, in rat liver microsomes(57,58), although the
required desaturation enzymes for PUFA conversion are pre-
sent and active in the fetal and newborn liver(59–62). Our
data suggest a significant involvement of the fetal metabolism
in the synthesis of n-6 LC-PUFA, because associations with
these fatty acids were only seen for the child genotypes. Actu-
ally, this result is supported by a couple of other studies on
LC-PUFA synthesis in preterm infants, showing that these
infants are capable of synthesising LC-PUFA from their 18C
precursors at the time they should be in utero (63–65).
Additionally, studies in fetal rat liver suggested that the rat
fetus is increasingly capable of synthesising 20 : 4n-6 with
advancing length of gestation, and near term relies to a
lesser extent on provision of 20 : 4n-6 from the maternal
organism(66). Rat liver D-5 desaturase activity increased
3-fold up to term, whereas the activity in the maternal rat
liver decreased 2–3 times. These data combined with the
experimental data reported in the present paper strongly
support that it is very likely that the fetus is capable of synthe-
sising LC-PUFA at a significant rate. Whether the fetus acquires
this ability in the course of gestation or whether fetal fatty acid
synthesis takes place also in the first trimesters of pregnancy
cannot be inferred from the present study. The observation
that the content of DHA in cord plasma was dependent on
both maternal and child genotypes in the present study is in
concordance with the results of previous studies: on the one
hand there is preferential transfer of DHA from the mother
to the fetus during pregnancy(57–59), and on the other hand
the fetus is capable of synthesising additional DHA by
itself(63–65), which might be necessary to satisfy the high
fetal demand of DHA during pregnancy.
Haplotype analyses might suggest specific SNP effects
In general, the associated SNP showed consistent effects on
fatty acid levels. The SNP rs498793, however, which is in nega-
tive LD with the other SNP reflecting an excess of the trans
compared with the cis configurations of minor alleles in
double heterozygotes (D’ , –0·35; P,6·4 £ 10245), showed
opposite effects as already reported by Bokor et al.(19). For
example, AA levels were elevated in carriers of the minor
allele of this SNP, whereas they were reduced in minor allele
carriers of all other SNP. We also obtained similar results in
our previous study on maternal FADS genotypes and maternal
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erythrocyte fatty acid levels(21). The isolated effect of this SNP,
which is located in an intronic FADS2 region, might be
interesting for future functional investigations. The presence
of the minor allele of this SNP on the second most common
haplotype (Hap3; frequency 17 %), which produced larger
effect sizes than the associated SNP, supports the special role
of this SNP.
Additionally, regression coefficients of haplotypes that were
generated from a region of high LD (rs174548 to rs174579)
might suggest a specific effect of SNP rs968567. Hap3 and
Hap5 differ only in the presence or absence of the rs968567
minor allele (see online Supplementary Table 5) and clear
differences on fatty acid levels were detected between these
two haplotypes. Although Hap3 occurred only at a frequency
of 1·6 % (which might explain some of the non-significant
results compared with Hap5), these results might also suggest
a specific effect of the minor allele for SNP rs968567 on fatty
acid metabolism. This is supported by our previous in vitro
study on functional effects of this SNP on FADS2 promoter
activity and transcription factor binding(51). Further studies
are needed to decipher the exact effect of this SNP on
desaturase activity.
Possible explanations for weak or lack of associations with
specific fatty acids
It merits mentioning that cord blood 18 : 2n-6 amounts were
nearly seventy times greater than the 18 : 3n-3 amount (9·74
v. 0·14 %). This high abundance may have made an impact
on the conversion of 18 : 3n-3 to 20 : 5n-3 and 22 : 6n-3,
which possibly explains the weaker associations observed
for these fatty acids. Another reason for weaker associations
with n-3 fatty acids might be that supply with these fatty
acids is more dependent on nutritional influences than the
n-6 fatty acids, which are more dependent on endogenous
synthesis.
The lack of associations between maternal genotypes and
some fatty acids, particularly the more highly desaturated
n-6 fatty acids, in cord blood multivariable analyses,
compared with strong associations being observed in the
maternal circulation(21), may have different possible expla-
nations. Fetal demand might be so high that maternal supply
becomes exhausted, with associations consequentially only
reflecting the fetal metabolism. Where maternal associations
are strong, particularly for the less desaturated n-6 fatty
acids, this may suggest an abundant supply from the
mother. It is perhaps to be expected that the fetal metabolism
will only operate to overcome any deficiency in the supply so
that offspring genetic associations will tend to occur where
there is less evidence of maternal genetic associations and
vice versa. It is interesting that the fatty acids 20 : 3n-6 and
20 : 4n-6 reflected a more equal contribution from maternal
supply and fetal metabolism than fatty acids at either extreme
of the metabolic pathway.
An alternative explanation for the lack of maternal associ-
ations may involve the placental transfer not occurring at
a fixed rate but related to maternal levels or materno–fetal
gradients. Such compensatory mechanisms might mask the
effects of genetic variation in the maternal circulation.
Whether placental transfer mechanisms would not only pre-
ferentially transport specific fatty acids to the fetus but might
also be able to increase transfer rates at low maternal levels
of specific fatty acids is currently unknown and requires
further investigation.
Study limitation
One of the limitations of the present study might be that we
determined fatty acid amounts in umbilical cord vein
plasma, which represents the part of the maternal–fetal circu-
lation system that comes from the maternal circulation and
goes to the child via the placenta and umbilical cord. In con-
trast, arterial blood flows from the child back to the placenta,
and might therefore represent the fetal status better than the
venous blood. Indeed there is evidence to support this view,
for example, AA can flow from the fetal circulation back to
the mother(25). Such effects will weaken the fetal genetic
signal in venous blood compared with arterial blood. How-
ever, it would seem unlikely that such processes could totally
eliminate the fetal signal; rather, there might be an underesti-
mation of the effect of the fetal metabolism. However, it has
been shown in a couple of studies that the fatty acid compo-
sition does not differ significantly between arterial and venous
cord blood(67,68). These studies would suggest that these
effects are relatively minor when one analyses composition
as a percentage of total fatty acids rather than concentrations.
Therefore, our overall conclusion that fetal metabolism is of
influence should be correct.
Conclusion
The present study is the first to analyse the influence
of maternal and offspring FADS polymorphisms on venous
cord plasma fatty acid levels in a large birth cohort. We con-
clude that FADS genotypes significantly contribute to deter-
mining cord blood n-6 and n-3 LC-PUFA composition.
Fetal metabolism seems important for neonatal supply of
n-6 LC-PUFA but to a lower extent for neonatal supply of
n-3 LC-PUFA. Two SNP in the FADS2 gene might have
specific effects on fatty acid levels as suggested by haplotype
analysis.
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